These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17646278

  • 1. Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol.
    Hiratsuka M, Hinai Y, Sasaki T, Konno Y, Imagawa K, Ishikawa M, Mizugaki M.
    Drug Metab Dispos; 2007 Oct; 35(10):1730-2. PubMed ID: 17646278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies.
    Desta Z, Soukhova N, Mahal SK, Flockhart DA.
    Drug Metab Dispos; 2000 Jul; 28(7):789-800. PubMed ID: 10859153
    [Abstract] [Full Text] [Related]

  • 4. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.
    Muschler E, Lal J, Jetter A, Rattay A, Zanger U, Zadoyan G, Fuhr U, Kirchheiner J.
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):374-9. PubMed ID: 19614891
    [Abstract] [Full Text] [Related]

  • 5. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
    Yoon YJ, Kim KB, Kim H, Seo KA, Kim HS, Cha IJ, Kim EY, Liu KH, Shin JG.
    Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A, Mizuno Y, Natsui K, Yabuki M, Komuro S, Kanamaru H.
    Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
    Filppula AM, Laitila J, Neuvonen PJ, Backman JT.
    Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.
    Zhou D, Andersson TB, Grimm SW.
    Drug Metab Dispos; 2011 Apr; 39(4):703-10. PubMed ID: 21177984
    [Abstract] [Full Text] [Related]

  • 14. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
    Fukasawa M, Nishida H, Sato T, Miyazaki M, Nakaya H.
    J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926
    [Abstract] [Full Text] [Related]

  • 15. Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes.
    Wormhoudt LW, Ploemen JH, de Waziers I, Commandeur JN, Beaune PH, van Bladeren PJ, Vermeulen NP.
    Chem Biol Interact; 1996 Sep 06; 101(3):175-92. PubMed ID: 8870687
    [Abstract] [Full Text] [Related]

  • 16. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA, Chen WG, Sadeque AJ.
    Drug Metab Dispos; 2012 Apr 06; 40(4):761-71. PubMed ID: 22266842
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
    Fischer V, Johanson L, Heitz F, Tullman R, Graham E, Baldeck JP, Robinson WT.
    Drug Metab Dispos; 1999 Mar 06; 27(3):410-6. PubMed ID: 10064574
    [Abstract] [Full Text] [Related]

  • 20. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
    Akutsu T, Kobayashi K, Sakurada K, Ikegaya H, Furihata T, Chiba K.
    Drug Metab Dispos; 2007 Jan 06; 35(1):72-8. PubMed ID: 17020955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.